Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Parand Salmassinia, President of Beauty & Care, on dsm-firmenich's PARSOL® Shield - Happi
The Happi Podcast

Parand Salmassinia, President of Beauty & Care, on dsm-firmenich’s PARSOL® Shield

It is the first new UV filter added to the OTC monograph since the late 1990s.

Released By dsm-firmenich


The US FDA added bemotrizinol, under the trademark PARSOL® Shield by dsm-firmenich, to the list of permitted sunscreen active ingredients—marking the first new UV filter added to the OTC monograph since the late 1990s. It is a remarkable milestone as skin cancer is truly on the rise in the US.

In this episode of The Happi Podcast, we speak with Parand Salmassinia, president of Beauty & Care, dsm-firmenich, about this major milestone for the industry and what comes next.

In this Happi podcast, you will hear about:

  • The impact of Bemotrizinol, PARSOL® Shield, and its approval by the US FDA as a UV filter in the US.
  • How dsm-firmenich advocated for the safety and science of BEMT.
  • Benefits that this filter will bring to the US suncare industry, from formulators to consumers.
  • Scientific substantiation: an extensive study conducted with diverse skin types.
  • When the first products with PARSOL® Shield are expected to hit the market in the US.
  • dsm-firmenich’s commitment to skin cancer prevention and public health.

For more on PARSOL® Shield, see the August issue of Happi, and visit the dsm-firmenich website.

Request more information from dsm-firmenich

Keep up with the story. Subscribe to the Happi free daily
newsletter

Topics